ScripsAmerica Inc. announced that the company has signed a 2-year manufacturing supply agreement with the manufacturer of its RapiMed(R) children's pain reliever and fever reducer. The recently signed agreement formalizes the working relationship between ScripsAmerica and RapiMed(R)'s manufacturer. The two companies have been working together and just completed ScripsAmerica's first order ticketed for Hong Kong in the amount of $200,000.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 141 | |
-39.97% | 1.38TCr | |
-26.34% | 1.15TCr | |
+14.31% | 640.59Cr | |
-20.28% | 632.32Cr | |
-11.33% | 597.15Cr | |
+72.00% | 499.75Cr | |
-3.36% | 463.07Cr | |
-6.21% | 396.28Cr | |
-18.47% | 324.16Cr |
- Stock Market
- Equities
- SCRCQ Stock
- News ScripsAmerica, Inc.
- ScripsAmerica Enters Supply Agreement with RapiMed(R) Manufacturer